These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8494782)

  • 1. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
    Wu SP; Sun LZ; Willson JK; Humphrey L; Kerbel R; Brattain MG
    Cell Growth Differ; 1993 Feb; 4(2):115-23. PubMed ID: 8494782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM; Infante D; Winawer S; Friedman E
    Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S; Huang F; Hafez M; Winawer S; Friedman E
    Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine transforming growth factor beta 1 modulates the expression of integrin alpha 5 beta 1 in human colon carcinoma FET cells.
    Wang D; Zhou GH; Birkenmeier TM; Gong J; Sun L; Brattain MG
    J Biol Chem; 1995 Jun; 270(23):14154-9. PubMed ID: 7539800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine TGFalpha expression in the regulation of initiation of human colon carcinoma growth.
    Wang D; Li W; Jiang W; Humphrey LE; Howell GM; Brattain MG
    J Cell Physiol; 1998 Dec; 177(3):387-95. PubMed ID: 9808147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA; Ziober BL; Morris SL; Mulder KM
    Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
    Yang H; Kyo S; Takatura M; Sun L
    Cell Growth Differ; 2001 Feb; 12(2):119-27. PubMed ID: 11243466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA; Sergina N; Yang H; Ziober B; Willson JK; Zborowska E; Humphrey LE; Fan R; Ko TC; Brattain MG; Howell GM
    Cancer Res; 2003 Aug; 63(15):4731-8. PubMed ID: 12907656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
    Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
    Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of autocrine gastrin expression by the TGF alpha autocrine loop.
    Howell GM; Ziober BL; Humphrey LE; Willson JK; Sun L; Lynch M; Brattain MG
    J Cell Physiol; 1995 Feb; 162(2):256-65. PubMed ID: 7822434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of transfection of sense- and antisense-TGF beta 1 gene on human pulmonary giant cell carcinoma cell proliferation].
    Yang H; Lu Y; Shen H
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):89-92. PubMed ID: 10743067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
    Periyasamy S; Sun L; Gentry LE; Brattain MG
    J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
    Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic consequences of transforming growth factor beta1 gene ablation in murine embryonic fibroblasts: autocrine control of cell proliferation and extracellular matrix biosynthesis.
    Sudarshan C; Yaswen L; Kulkarni A; Raghow R
    J Cell Physiol; 1998 Jul; 176(1):67-75. PubMed ID: 9618146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.